Longview Acquisition Corp. II
Status: Liquidated
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $690.00M |
|---|---|
| IPO Date | Mar 19, 2021 |
| CEO | John Rodin |
| Left Lead | UBS |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Dec 14, 2022 |
| Closing Date | Dec 21, 2022 |
LGV
LGV.U
LGV/W
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Longview Acquisition Corp. II:
- Structure and cap table
- 5 directors & officers
- 18 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Larry Robbins | 51 | Chairman |
| John Rodin | 45 | Chief Executive Officer and Director |
| Mark Horowitz | 49 | Chief Financial Officer |
| Shalinee Sharma | 43 | Director |
| Brian Zied | 51 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Filings
Sign in to view 18 filings.